Troy Wichterman Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Troy Wichterman is Chief Financial Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 150,746 shares of BLFS, which is worth approximately $3.63 Million. The most recent transaction as insider was on Mar 22, 2023, when has been sold 310 shares (Common Stock) at a price of $21.84 per share, resulting in proceeds of $6,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 151K
17.78% 3M change
23.79% 12M change
Total Value Held $3.63 Million

Troy Wichterman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2023
SELL
Open market or private sale
$6,770 $21.84 p/Share
310 Reduced 0.45%
67,850 Common Stock
Mar 20 2023
SELL
Open market or private sale
$206,400 $20.64 p/Share
10,000 Reduced 12.79%
68,160 Common Stock
Mar 20 2023
BUY
Exercise of conversion of derivative security
$1,932 $2.06 p/Share
938 Added 1.19%
78,160 Common Stock
Mar 07 2023
SELL
Open market or private sale
$711 $22.95 p/Share
31 Reduced 0.04%
77,222 Common Stock
Mar 01 2023
SELL
Open market or private sale
$35,854 $22.75 p/Share
1,576 Reduced 2.0%
77,253 Common Stock
Feb 21 2023
SELL
Open market or private sale
$2,511 $21.47 p/Share
117 Reduced 0.15%
78,829 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
34,295 Added 30.28%
78,946 Common Stock
Dec 22 2022
SELL
Open market or private sale
$9,266 $17.55 p/Share
528 Reduced 1.17%
44,651 Common Stock
Nov 29 2022
SELL
Open market or private sale
$1,036 $19.93 p/Share
52 Reduced 0.11%
45,179 Common Stock
Nov 22 2022
SELL
Open market or private sale
$2,444 $20.2 p/Share
121 Reduced 0.27%
45,231 Common Stock
Sep 23 2022
SELL
Open market or private sale
$12,467 $21.91 p/Share
569 Reduced 1.24%
45,352 Common Stock
Aug 31 2022
SELL
Open market or private sale
$1,195 $23.44 p/Share
51 Reduced 0.11%
45,921 Common Stock
Aug 16 2022
SELL
Open market or private sale
$2,878 $24.81 p/Share
116 Reduced 0.25%
45,972 Common Stock
Aug 14 2022
BUY
Grant, award, or other acquisition
-
234 Added 0.51%
46,088 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
299 Added 0.65%
45,854 Common Stock
Jul 17 2022
BUY
Grant, award, or other acquisition
-
362 Added 0.79%
45,555 Common Stock
Jul 03 2022
BUY
Grant, award, or other acquisition
-
394 Added 0.86%
45,193 Common Stock
Jun 24 2022
SELL
Open market or private sale
$7,273 $15.95 p/Share
456 Reduced 1.01%
44,799 Common Stock
Jun 19 2022
BUY
Grant, award, or other acquisition
-
418 Added 0.92%
45,255 Common Stock
Jun 05 2022
BUY
Grant, award, or other acquisition
-
419 Added 0.93%
44,837 Common Stock
May 27 2022
SELL
Open market or private sale
$625 $14.53 p/Share
43 Reduced 0.1%
44,418 Common Stock
May 22 2022
BUY
Grant, award, or other acquisition
-
448 Added 1.0%
44,461 Common Stock
May 13 2022
SELL
Open market or private sale
$1,540 $12.32 p/Share
125 Reduced 0.28%
44,013 Common Stock
Mar 22 2022
SELL
Open market or private sale
$12,706 $23.06 p/Share
551 Reduced 1.23%
44,138 Common Stock
Mar 01 2022
SELL
Open market or private sale
$1,332 $23.78 p/Share
56 Reduced 0.26%
21,324 Common Stock
TW

Troy Wichterman

Chief Financial Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS